中文 | English
Return
Total: 8 , 1/1
Show Home Prev Next End page: GO
Author:(De-Quan DING)

1.Effects of ulinastatin on cerebral inflammatory response during cardiopulmonary bypass.

Ding-quan ZOU ; Jian-mei ZHOU ; Ye-tian CHANG ; Xiao-jing HE ; Gui-xiu YUAN ; De-ming WANG ; He-guo LUO

Journal of Central South University(Medical Sciences) 2005;30(4):420-423

2.Effect of electro-acupuncture combined with early rehabilitation on motor function and expressions of CD11b/CD18 and tumor necrosis factor-α in patients with acute cerebral infarction

Jin-Liang WANG ; Feng TAN ; De-Quan DING ; Tao HUANG ; Hai-Ke WU ; Ming-Xia ZHANG

Chinese Journal of Neuromedicine 2009;8(6):569-573,577

3.Somatosensory disinhibition in patients with paroxysmal kinesigenic dyskinesia.

Hua WEI ; Ying SUN ; Hai CHEN ; De-quan WANG ; Li-ping LI ; Yan DING ; Ai-hua LIU ; Chang-feng LU ; Yu-ping WANG

Chinese Medical Journal 2012;125(5):838-842

4.Isolation and identification of side population cells in human lung adenocarcinoma cell line A549.

Tong XIE ; Li LI ; Dan-rong LI ; Nai-quan MAO ; De-seng LIU ; Chuan-tian ZUO ; Wei ZHANG ; Ding-ming HUANG

Chinese Journal of Oncology 2011;33(2):84-90

5.Application value of enhanced recovery after surgery in the radical distal gastrectomy

De-Hai WANG ; Zhi-Peng JI ; Yi-Feng ZANG ; Quan-Hui LI ; Bing-Tian LIU ; Xiang-Rui MENG ; Yin-Lu DING

Chinese Journal of Current Advances in General Surgery 2018;21(1):17-20

6.Isolation, identification and characterization of SFTS bunyavirus from ticks collected on the surface of domestic animals.

Xiao-Lin JIANG ; Xian-Jun WANG ; Jian-Dong LI ; Shu-Jun DING ; Quan-Fu ZHANG ; Jing QU ; Shuo ZHANG ; Chuan LI ; Wei WU ; Mei JIANG ; Mi-Fang LIANG ; Zhen-Qiang BI ; De-Xin LI

Chinese Journal of Virology 2012;28(3):252-257

7.Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis.

Le-ya HE ; Xin WEI ; Lei DU ; Lu LIU ; Feng XU ; Jiang MIN ; Chuan LI ; De-ding TAO ; Quan CHEN ; Jun-bo HU ; Jian-ping GONG

Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(2):205-211

8.First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer.

Zhong-zhen GUAN ; Dong-geng LIU ; Bao-ming YU ; Wei-qin WU ; De SHI ; Yu ZHAO ; Yu-quan WEI ; Li-qun ZOU ; Xiao-ding WU ; Wen ZHUANG ; Feng-yi FENG ; Pin ZHANG ; Shi-ying YU ; Hui-hua XIONG ; Qiang FU ; Shu ZHENG ; Jian-jin HUANG ; Gang WU ; Chuan-yong YANG ; Sheng-rong SUN ; Qing-lan RUAN

Chinese Journal of Oncology 2004;26(2):119-121

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 8 , 1/1 Show Home Prev Next End page: GO